source
- Scribe Therapeutics raises $129 million in gene-editing IPO, debuting on NasdaqScribe Therapeutics completed an initial public offering that raised close to $129 million. The company sold 8.58 million shares at $15 each and will trade on Nasdaq under the ticker SCTX. The off…
- Novo Nordisk seeks court order to halt Lilly GLP-1 ads as Merck announces HIV PrEP partnershipNovo Nordisk asked a New Jersey federal court to temporarily block Eli Lilly's GLP-1 advertisements, claiming the ads are misleading. Merck disclosed that it has entered into a partnership focused…